Fresenius Medical Care

Fresenius Medical Care, one of the world's largest providers of kidney care products and services with approximately 4,000 outpatient dialysis centers globally, operated its product development, manufacturing, and product management functions on paper-based workflows. In medical device manufacturing — where regulatory documentation accuracy, version control, and audit traceability are non-negotiable — paper-based systems introduce serious operational risk. Fragmented documentation across global sites slowed regulatory submissions, extended design iteration cycles, and created inconsistencies in how dialysis solutions and extracorporeal blood treatment products moved from development to production. The cumulative effect was a compressed competitive position and slower time to market in a sector where product reliability directly affects patient outcomes.

Fresenius Medical Care undertook a comprehensive PLM (Product Lifecycle Management) transformation in partnership with Rockwell Automation, with digital twin technology at its core. The initiative replaced paper-based documentation and processes with fully digital workflows spanning the complete product lifecycle — from design and engineering through manufacturing execution and product management. Digital twins provided virtual representations of products and production processes, enabling engineering teams to simulate, validate, and iterate earlier in the development cycle without relying on physical prototypes. The transformation created a unified, digital source of truth for product data across Fresenius's distributed global manufacturing operations, connecting teams across sites and ensuring consistent, traceable documentation aligned with medical device regulatory requirements.

The PLM and digital twin transformation successfully moved Fresenius Medical Care off paper-based operations across global product development and manufacturing functions. Key outcomes reported include:

• Full digitization: Product development, manufacturing workflows, and product management documentation transitioned from paper to digital systems across global operations
• Operational reach: Digitized manufacturing processes now support the product supply chain serving approximately 4,000 dialysis centers worldwide
• Development velocity: Removal of paper-based bottlenecks improved speed to market for dialysis solutions and extracorporeal blood treatment products
• Process consistency: Cross-site teams gained access to a unified digital record, reducing version control errors and improving collaboration across geographies

• In regulated medical device manufacturing, PLM digitization must precede advanced AI adoption — digital twin value depends entirely on clean, structured, accessible product data
• Paper-to-digital transformation at global scale requires mapping documentation workflows to regulatory compliance requirements from day one, not retroactively
• Choosing a technology partner like Rockwell Automation that spans manufacturing automation and enterprise software reduces integration complexity across multi-site deployments
• The ROI case for digital twins compounds with operational scale — manufacturers serving thousands of facilities or managing complex, multi-variant product lines see disproportionately higher returns
• In life-critical industries, faster time to market carries patient outcome implications that strengthen internal justification for transformation investment beyond operational efficiency alone